Champions Oncology, Inc.
CSBR
$7.63
$0.222.97%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,583.49% | 277.67% | 135.15% | 151.17% | 95.74% |
| Total Depreciation and Amortization | -13.79% | -17.26% | -17.56% | 0.90% | 7.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -45.25% | -31.92% | -77.73% | -44.33% | -15.77% |
| Change in Net Operating Assets | 339.45% | -1,411.20% | -185.75% | 29.28% | -13,545.83% |
| Cash from Operations | 478.19% | 153.32% | -148.05% | 107.79% | -162.43% |
| Capital Expenditure | -8,533.33% | 54.35% | -18.99% | -- | 100.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8,533.33% | 54.35% | -18.99% | -- | 100.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -11.76% | 50.00% | -- | -- |
| Issuance of Common Stock | 500.00% | -- | 15.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.51% | 100.00% | 78.36% | 93.73% | 50.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 455.84% | 142.87% | -121.43% | 105.22% | -21.15% |